v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Total Revenues$78,703 $101,685 $137,521 $155,018 
Less:
Employee related expenses23,430 18,581 44,432 38,119 
Commercial related expenses7,084 7,273 14,124 12,612 
Outside clinical trial related expenses7,409 3,232 14,336 7,603 
Cost of product sales8,525 4,504 13,131 8,913 
Consultants and third-party services4,225 3,209 8,231 6,618 
Other segment items4,455 3,783 7,807 7,277 
Interest (income) expense and other, net(10)1,121 218 2,383 
Provision for income taxes6,295 369 9,298 434 
Segment income$17,290 $59,613 $25,944 $71,059 
There are no reconciling items or adjustments between segment income presented above and net income as presented in our statements of operations. The CODM does not review assets in evaluating the segment performance, accordingly, such information is not presented.
For details of revenues disaggregated by category, see “Note 3 – Revenues.”
Employee related expenses primarily consist of salaries, employee benefits, other employee related expenses and stock-based compensation expense. For additional details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily consist of travel related expenses, business insurance, taxes and licenses, and subscription services.